Description
Nuvalent is hiring a Director, Thought Leader Liaison to lead commercial engagement with lung-cancer thought leaders and key opinion leaders as the company prepares for the market launch of Zidesamtinib and Neladalkib. The role coordinates launch and brand strategies, manages KOL relationships and promotional speakers, supports advisory boards and congresses, captures therapeutic and competitive insights, and ensures compliant customer engagement. It requires a bachelor’s degree, 10+ years of biopharma experience including oncology launch experience, 3+ years as a Thought Leader Liaison in oncology, and 5+ years of U.S. commercial oncology experience. The position offers an annual salary of $216,000–$252,000 USD and medical, dental, and vision insurance.
